The day of reckoning is here for AstraZeneca as cheap generic rivals to blockbuster cholesterol drug, Crestor (rosuvastatin) were launched yesterday in the US. Despite a last-ditch court battle ...

This has helped the company overcome one of the worst patent cliffs in the industry as Crestor and several other blockbusters encountered generic competition. Income arising from the upfront and ...